Thorne HealthTech, Inc. (Nasdaq: THRN), relating to its proposed sale to L. Catterton. Under the terms of the agreement, THRN shareholders are expected to receive $10.20 in cash per share they own.
Thorne HealthTech, Inc. (Nasdaq: THRN), relating to its proposed sale to L. Catterton. Under the terms of the agreement, THRN shareholders are expected to receive $10.20 in cash per share they own.